Terms: = Germ cell tumor AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
3203 results:
1. Simulating BRAFV600E-MEK-erk signalling dynamics in response to vertical inhibition treatment strategies.
De Carli A; Kapelyukh Y; Kursawe J; Chaplain MAJ; Wolf CR; Hamis S
NPJ Syst Biol Appl; 2024 May; 10(1):51. PubMed ID: 38750040
[TBL] [Abstract] [Full Text] [Related]
2. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma cells.
Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
[TBL] [Abstract] [Full Text] [Related]
3. Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy.
Patra S; Roy PK; Dey A; Mandal M
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189105. PubMed ID: 38701938
[TBL] [Abstract] [Full Text] [Related]
4. ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling.
Ciccone V; Simonis V; Del Gaudio C; Cucini C; Ziche M; Morbidelli L; Donnini S
Biochem Pharmacol; 2024 Jun; 224():116252. PubMed ID: 38701866
[TBL] [Abstract] [Full Text] [Related]
5. A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases.
Bhusare N; Kumar M
Oncol Res; 2024; 32(5):849-875. PubMed ID: 38686058
[TBL] [Abstract] [Full Text] [Related]
6.
Zhao A; Wang Y; Wang Z; Shao Q; Gong QI; Zhu H; Shen S; Liu HU; Chen X
Oncol Res; 2024; 32(5):983-998. PubMed ID: 38686044
[TBL] [Abstract] [Full Text] [Related]
7. A Phase II Study of erk Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma.
Buchbinder EI; Cohen JV; Tarantino G; Lian CG; Liu D; Haq R; Hodi FS; Lawrence DP; Giobbie-Hurder A; Knoerzer D; Sullivan RJ
Cancer Res Commun; 2024 May; 4(5):1321-1327. PubMed ID: 38683104
[TBL] [Abstract] [Full Text] [Related]
8. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells.
Madej E; Lisek A; Brożyna AA; Cierniak A; Wronski N; Deptula M; Wardowska A; Wolnicka-Glubisz A
J Cancer Res Clin Oncol; 2024 Apr; 150(4):209. PubMed ID: 38656555
[TBL] [Abstract] [Full Text] [Related]
9. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract] [Full Text] [Related]
10. A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma.
Su C; Zhu X; Wang Q; Zhang J
J Cardiothorac Surg; 2024 Apr; 19(1):198. PubMed ID: 38600577
[TBL] [Abstract] [Full Text] [Related]
11. Cannabidiol induces erk activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells.
Kim NY; Shivanne Gowda SG; Lee SG; Sethi G; Ahn KS
Chem Biol Interact; 2024 May; 394():110995. PubMed ID: 38583854
[TBL] [Abstract] [Full Text] [Related]
12. has-miR-134-5p inhibits the proliferation and migration of glioma cells by regulating the BDNF/erk signaling pathway.
Guo Z; An P; Hong X
Aging (Albany NY); 2024 Apr; 16(7):6510-6520. PubMed ID: 38579169
[TBL] [Abstract] [Full Text] [Related]
13. Ergosterol promotes neurite outgrowth, inhibits amyloid-beta synthesis, and extends longevity: In vitro neuroblastoma and in vivo Caenorhabditis elegans evidence.
Sillapachaiyaporn C; Wongwan C; Mongkolpobsin K; Nilkhet S; Isidoro C; Chuchawankul S; Tencomnao T
Life Sci; 2024 May; 345():122606. PubMed ID: 38574884
[TBL] [Abstract] [Full Text] [Related]
14. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/erk signaling.
Gao Y; Du P
Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma cell Line.
Matus V; Castro-Guarda M; Cárcamo-Fierro J; Morera FJ; Zambrano A
Neurochem Res; 2024 May; 49(5):1373-1386. PubMed ID: 38512424
[TBL] [Abstract] [Full Text] [Related]
16. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
17. ACA-28, an erk MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer cells.
Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
[TBL] [Abstract] [Full Text] [Related]
18. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
[TBL] [Abstract] [Full Text] [Related]
19. Neuroprotective Effects of Polysaccharides and Gallic Acid from
Rangsinth P; Pattarachotanant N; Wang W; Shiu PH; Zheng C; Li R; Tencomnao T; Chuchawankul S; Prasansuklab A; Cheung TM; Li J; Leung GP
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474465
[TBL] [Abstract] [Full Text] [Related]
20. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
[TBL] [Abstract] [Full Text] [Related]
[Next]
